Hamed Hamed Dina, Rodríguez-Pérez Celia, Pruimboom Leo, Navarro-Ledesma Santiago
Clinical Medicine and Public Health Ph.D. Program, Faculty of Health Sciences, University of Granada, 18001 Granada, Spain.
Department of Physiotherapy, University Hospital of Melilla, C. Luis de Ostáriz 12, 52005 Melilla, Spain.
Healthcare (Basel). 2024 Dec 4;12(23):2444. doi: 10.3390/healthcare12232444.
Frozen shoulder (FS), or adhesive capsulitis, is a disabling condition characterized by pain and restricted shoulder mobility.
This study investigates the relationship between metabolic biomarkers-liver enzymes and thyroid function-and pain and shoulder functionality in patients with FS.
A total of 32 patients (22 women and 10 men) were included in this cross-sectional study. Participants underwent clinical evaluations and blood tests to assess metabolic biomarkers, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), and thyroid-stimulating hormone (TSH). Pain and functionality were measured using the Shoulder Pain and Disability Index (SPADI). Correlation and multiple regression analyses were performed to assess the associations between biomarkers, pain, and functionality.
Significant negative correlations were found between AST (r = -0.528, = 0.029), ALT (r = -0.533, = 0.027), GGT (r = -0.602, = 0.011), and TSH (r = -0.556, = 0.017) with total pain scores. A significant negative correlation was also observed between TSH and SPADI scores (r = -0.511, = 0.039). Multiple regression analysis showed that GGT (β = -0.335, = 0.008) and TSH (β = -0.298, = 0.014) were the strongest predictors of pain. These findings suggest that metabolic biomarkers, particularly liver enzymes and thyroid function, play a significant role in the pathophysiology of frozen shoulder. The results highlight the importance of assessing these biomarkers for better understanding and managing pain and functionality in patients with FS.
Further research is needed to explore the underlying mechanisms and potential therapeutic targets.
肩周炎(FS),即粘连性关节囊炎,是一种以疼痛和肩关节活动受限为特征的致残性疾病。
本研究调查代谢生物标志物——肝酶和甲状腺功能——与FS患者疼痛及肩部功能之间的关系。
本横断面研究共纳入32例患者(22例女性和10例男性)。参与者接受临床评估和血液检查以评估代谢生物标志物,包括天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、γ-谷氨酰转移酶(GGT)和促甲状腺激素(TSH)。使用肩痛和功能障碍指数(SPADI)测量疼痛和功能。进行相关性和多元回归分析以评估生物标志物、疼痛和功能之间的关联。
发现AST(r = -0.528,P = 0.029)、ALT(r = -0.533,P = 0.027)、GGT(r = -0.602,P = 0.011)和TSH(r = -0.556,P = 0.017)与总疼痛评分之间存在显著负相关。TSH与SPADI评分之间也观察到显著负相关(r = -0.511,P = 0.039)。多元回归分析表明,GGT(β = -0.335,P = 0.008)和TSH(β = -0.298,P = 0.014)是疼痛的最强预测因子。这些发现表明,代谢生物标志物,特别是肝酶和甲状腺功能,在肩周炎的病理生理学中起重要作用。结果强调了评估这些生物标志物对于更好地理解和管理FS患者的疼痛和功能的重要性。
需要进一步研究以探索潜在机制和潜在治疗靶点。